Epoch Biodesign Ltd

Epoch Biodesign Ltd is a small, active company based in London, UK, founded six years ago in 2019. With £3,156,136 in assets and a real registered address at 10 Finsbury Square, it employs seventeen people and is managed by two directors. Despite having no officially listed owners, the company is a regular importer of optical and medical tools and devices, with four months of import activity recorded, the latest being September 01, 2024.

The company operates in the research and experimental development on biotechnology industries. It's a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, and fewer than 50 employees. Its website is currently unavailable, making it difficult to assess its e-commerce presence or specific product offerings.

Financially, Epoch Biodesign Ltd shows some concerning trends. Cash and cash equivalents have plummeted by 59%, dropping to £2 million, while net current assets have fallen by 50% to £2.8 million. Creditors have increased significantly, rising by 170% to £310,000, suggesting potential cash flow pressures. Trade debtors have also increased, by 37%, reaching £890,000. Equity has decreased by 46%, dropping to £3.9 million. Despite these challenges, the company’s bank borrowings have increased by 2,400%, reaching £29,000. The company's accounts are unaudited, and no auditor is mentioned, which is common for small companies.

The significant decrease in cash reserves and the increase in liabilities suggest that Epoch Biodesign Ltd is burning through money. Whether this is a temporary setback or a longer-term issue remains to be seen. The company’s research-focused activities may require substantial investment, and the lack of owners could indicate a lean management structure, but it also raises questions about long-term stability.

Registered in England/Wales under the registration number 11824812, with a registered address at EC2A 1AJ, England, London, 10 Finsbury Square.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.